|
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
RECRUITINGN/ASponsored by Nanfang Hospital, Southern Medical University
Actively Recruiting
PhaseN/A
SponsorNanfang Hospital, Southern Medical University
Started2022-08-01
Est. completion2024-12-31
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05494086
Summary
Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).
Eligibility
Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. patients within 18--75 years old; 2. patients with a preoperative pathological diagnosis of gastric adenocarcinoma; 3. patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomography); 4. patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results; 5. patients without severe heart, liver, lung, or kidney dysfunction; 6. patients with an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1; and (7) patients with American Society of Anesthesiologists (ASA) I-II. Exclusion Criteria: 1. patients with a history of upperabdominal surgery; 2. patients who presentedas an emergency case; 3. patients with other histories of malignant diseases within 5 years; 4. patients with prior neoadjuvant chemotherapy or radiation therapy; and (5)patients who need simultaneous surgical treatment for other malignant diseases.
Conditions2
CancerGastric Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNanfang Hospital, Southern Medical University
Started2022-08-01
Est. completion2024-12-31
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05494086